Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants?

Fatma Nur Sari1, Zeynep Eras, Evrim Alyamac Dizdar

  • 1Neonatal Intensive Care Unit, Zekai Tahir Burak Maternity and Teaching Hospital, Ankara, Turkey. fatmanurselek@yahoo.com

Insights

Oral probiotics given to very low-birth-weight (VLBW) preterm infants to prevent necrotizing enterocolitis (NEC) did not impact growth or neurodevelopmental outcomes by 18 to 22 months corrected age.

Area of Science:

  • Neonatal research
  • Pediatric nutrition
  • Developmental pediatrics

Background:

  • Necrotizing enterocolitis (NEC) is a serious condition affecting very low-birth-weight (VLBW) preterm infants.
  • Oral probiotics are explored as a preventative measure for NEC.
  • Long-term effects of probiotic supplementation on VLBW infants require evaluation.

Purpose of the Study:

  • To assess the impact of oral probiotics on growth and neurodevelopment in VLBW preterm infants.
  • To determine if probiotic supplementation influences neurodevelopmental impairment at 18 to 22 months corrected age.
  • To evaluate the efficacy of early oral probiotic administration for NEC prevention and its long-term outcomes.

Main Methods:

  • Prospective follow-up of VLBW infants from a randomized controlled trial.
  • Growth parameters (weight, length, head circumference) were measured.
  • Cognitive and neuromotor development assessed using Bayley Scales of Infant Development II.
  • Sensory and neurological performance evaluated using standard techniques.

Main Results:

  • 174 VLBW infants (86 probiotics, 88 control) were evaluated at 18-22 months corrected age.
  • No significant differences observed in growth parameters between probiotic and control groups.
  • No significant differences found in cognitive, neuromotor, sensory, or neurological outcomes.

Conclusions:

  • Early oral probiotic administration to VLBW infants for NEC prevention did not alter growth outcomes.
  • Probiotic supplementation did not affect neuromotor, neurosensory, or cognitive development at 18-22 months corrected age.
  • Findings suggest no long-term benefit of this probiotic regimen on neurodevelopmental trajectories in VLBW infants.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...